Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.00    0.00 (0.00%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £7.31m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Trading Update

17 Jul 2025 07:00

RNS Number : 3858R
Transense Technologies PLC
17 July 2025
 

 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

 

17 July 2025

 

 

Transense Technologies plc

 

("Transense" or "the Company")

 

Year-end trading update

 

Transense Technologies plc, the provider of specialist sensor technology and measurement solutions, is pleased to issue a trading update for its financial year ended 30 June 2025 ("FY25") based on unaudited management information. The Company is continuing its growth trajectory and delivering on its strategic plan.

 

Financial highlights

 

Total revenue for the year increased by 33% to £5.6m (FY24: £4.2m), as follows:

 

  SAWsense revenue[1&3] up 120% to £1.1m (FY24: £0.5m)

  Translogik revenue up 18% to £1.3m (FY24: £1.1m)

  Bridgestone iTrack royalty income[3] up 19% to £3.1m (FY24: £2.6m)

 

SAWsense and Translogik combined revenue in the second half of the financial year was up 67% on the first half (FY25H2: £1.5m, FY25H1: £0.9m), demonstrating increasing traction and accelerating revenue growth within these product lines.

 

Adjusted PBT[2] for the year is expected to be approximately £1.6m; an increase of 8% on prior year (FY24: £1.4m), in line with market expectations.

 

Net cash at 30 June 2025 was £1.1m (30 June 2024: £1.3m), with a fourth quarter royalty receivable of approximately £0.8m[3] (30 June 2024: £0.7m) at the end of July.

 

Commercial and operational highlights

 

SAWsense

  Deepening customer relationships in aerospace, motorsport and eDrives sectors contributed to increased revenue

  Development projects underway with two leading global companies and a niche manufacturer in robotics

  Healthy pipeline of opportunities from both existing and new customers in focus markets

  Investment in next generation components and in-house production capabilities progressing on time and within budget

  Further strengthening of operational, technical, and business development teams to position the business for sustained expansion

 

Translogik

  New customer relationships and routes to market delivered overall sales growth, despite some headwinds in established premium commercial vehicle tyre market

  Established new distribution channels in the USA, Southeast Asia and South America

  Completed first software reseller agreement and closed initial contracts under subscription business model

  Reorganised business development activities to better align with future growth plan

  Development projects well underway for next generation product range and opening of new market sectors

 

Bridgestone iTrack royalty income

  Volume increase in installed base significantly ahead of expectation

  Royalty growth constrained by weakening US dollar in H2, partially mitigated by credit to opex from gains on FX hedging instruments

  Planned 40% reduction in unit royalty rate applies from July 2025 as per original agreement

 

Outlook and audited results

 

The directors are confident that both of the Company's operating businesses are well placed to deliver further growth in the upcoming financial year, and remain positive regarding future prospects.

 

Final audited results for the year ended 30 June 2025, together with a more detailed update on trading and outlook, are expected to be announced towards the end of September 2025.

 

Nigel Rogers, Executive Chairman commented:

 

"The increased traction within in our core product lines is demonstrated by our accelerating revenue growth and shows that our strategy is delivering. Going into the new financial year, we have strong pipeline giving management confidence in meeting market expectations for FY26 and remain excited about the opportunity to significantly scale the business over the coming years."

 

[1] SAWsense revenue includes grant income of £0.38m (FY24: £0.05m). 

[2] Net Profit Before Taxation before deduction of Share Based Payments charge

[3] Bridgestone iTrack royalty income and year end receivable are based on rates of foreign exchange prevailing at the year end. Actual rates may differ at the date of receipt.

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

Investor.relations@transense.co.uk

 

 

Notes to Editors:

 

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

 

SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software, and a growing list of international territory distribution partners.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKABKFBKDDOD
Date   Source Headline
28th Jan 20217:00 amRNSCompletion of Capital Reduction
21st Dec 20207:00 amRNSIssue of Options
17th Dec 20201:19 pmRNSResult of AGM
17th Dec 20207:00 amRNSAGM Update, new Website & Investor Presentation
9th Dec 20207:00 amRNSEstablishment of SAW Commercial Advisory Panel
23rd Nov 20207:00 amRNSPosting of Annual Report and Notice of AGM
6th Nov 20203:38 pmRNSDirector/PDMR Shareholding
22nd Oct 20208:45 amRNSHolding(s) in Company
20th Oct 202012:09 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSFinal results for the year ended 30 June 2020
19th Oct 20207:00 amRNSChange of Nomad and Broker & AIM Rule 17 update
12th Oct 20207:00 amRNSNotice of Results and Investor Presentation
10th Sep 20207:00 amRNSFinal consideration for iTrack transfer
25th Aug 202010:23 amRNSDirector/PDMR Shareholding
24th Aug 20209:27 amRNSHolding(s) in Company (Replacement)
20th Aug 20205:02 pmRNSHolding(s) in Company
8th Jul 20204:16 pmRNSDirector/PDMR Shareholding
7th Jul 20203:38 pmRNSHolding(s) in Company
3rd Jul 202011:30 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSInvestor Presentation
1st Jul 20206:12 pmRNSHolding(s) in Company
26th Jun 20201:54 pmRNSDirector/PDMR Shareholding
26th Jun 20207:00 amRNSGrant of Options/PDMR Dealing
25th Jun 20204:41 pmRNSDirector/PDMR Shareholding
25th Jun 20202:10 pmRNSDirector/PDMR Shareholding
25th Jun 20207:01 amRNSStrategic Update
25th Jun 20207:00 amRNSBridgestone Granted Worldwide iTrack Licence
12th Jun 202010:40 amRNSUpdate relating to the JCA with Bridgestone
1st Jun 20207:00 amRNSUpdate relating to the JCA with Bridgestone
5th May 20202:39 pmRNSHolding(s) in Company
1st May 20207:00 amRNSUpdate relating to the JCA with Bridgestone
16th Mar 20207:00 amRNSFurther Working Capital Loan Agreement
20th Feb 20207:00 amRNSInterim Results
20th Feb 20207:00 amRNSInterim Results
19th Feb 20207:00 amRNSChanges to Board responsibilities
13th Feb 20207:01 amRNSNotice of Interim Results
13th Feb 20207:00 amRNSExtension to Agreement with Bridgestone
19th Dec 20194:14 pmRNSResult of AGM
19th Dec 20197:00 amRNSAGM Statement
19th Nov 20197:00 amRNSNotice of AGM
15th Nov 20194:53 pmRNSHolding(s) in Company
7th Nov 20191:13 pmRNSHolding(s) in Company
26th Sep 20197:00 amRNSFinal results for the year ended 30 June 2019
14th Aug 20199:09 amRNSHolding(s) in Company
13th Aug 20192:45 pmRNSAwards of Options
13th Aug 20197:00 amRNSJoint Collaboration Agreement with Bridgestone
30th Jul 20197:00 amRNSTrading Update
1st Jul 201912:02 pmRNSHolding(s) in Company
30th Apr 20194:10 pmRNSHolding(s) in Company
29th Apr 20198:52 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.